ROBAXIN-750 Drug Patent Profile
✉ Email this page to a colleague
When do Robaxin-750 patents expire, and what generic alternatives are available?
Robaxin-750 is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in ROBAXIN-750 is methocarbamol. There are twenty-seven drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Robaxin-750
A generic version of ROBAXIN-750 was approved as methocarbamol by PRINSTON INC on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROBAXIN-750?
- What are the global sales for ROBAXIN-750?
- What is Average Wholesale Price for ROBAXIN-750?
Summary for ROBAXIN-750
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,585 |
| DailyMed Link: | ROBAXIN-750 at DailyMed |
Recent Clinical Trials for ROBAXIN-750
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | Phase 4 |
| Medical College of Wisconsin | Phase 4 |
US Patents and Regulatory Information for ROBAXIN-750
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | ROBAXIN-750 | methocarbamol | TABLET;ORAL | 011011-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
